Coronil

Subject: Science and Technology

Context: Coronil has received AYUSH certification as “Supportive measure for Covid-19.

Concept:

According to the firm PatanjaliDivya, the coronil has certification from AYUSH Ministry as per WHO norms as a drug that can be used as “supporting measure in Covid-19” and as an immuno-booster.
The firm said it received Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme.
Last year the AYUSH Ministry banned Patanjali from selling Coronil tablet when it projected it as a “cure” and sought information on its trials.

About CoPP

It is a WHO recommended certificate. The format is as per WHO guidelines and uniform across the world.
It is mandatory to submit it to the importing country when the product is intended for licensing authorization or renewal of registration.
It is recommended by WHO to facilitate the importing countries in assessing the quality of pharma products. Also, it is a prerequisite of importation and registration.
CDSCO (It is India’s national regulatory body for pharmaceuticals and medical devices under the Ministry of Health) officers check and scrutinize the application and implement WHO standards.